SEATTLE –– Ground broke Wednesday on a new 197,000-sq.-ft., 9-story, purpose-built life sciences development in downtown Seattle named 222 Fifth. The project is a joint venture between LPC West and Intercontinental Real Estate Corporation, with CBRE serving as leasing advisor. 222 Fifth is LPC’s second life sciences project in Seattle. Construction is scheduled to complete […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
San Rafael-based LRE & Companies has won Site Plan and Architectural Commission...
ByThe RegistryNovember 12, 2026An entity affiliated with industrial investor Westcore has paid $51.1 million for...
ByThe RegistryNovember 12, 2026The 2024 and 2025 buildings are made up almost entirely of studios...
ByThe RegistryNovember 12, 2026The 1987 complex near Interstate 205 and State Route 500 is the...
ByThe RegistryNovember 12, 2026